Author Correction: Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial
- Oscar Arrieta
- Luis Lara-Mejía
- Eduardo Rios-Garcia
- Enrique Caballé-Perez
- Luis Cabrera-Miranda
- Maritza Ramos-Ramírez
- David Dávila-Dupont
- Andrés F. Cardona
- Graciela Cruz-Rico
- Jordi Remon
- Alexandra Garcilazo-Reyes
- Rafael Rosell
2025-12-12